Publication

Brief Report: Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma

Journal Paper/Review - Aug 21, 2018

Units
PubMed
Doi

Citation
Metaxas Y, Froesch P, Löffler-Baumann M, Pratsch-Peter S, Russell P, Mingrone W, Savic S, Thapa B, Früh M, Pless M, von Moos R, Mauti L, O'Byrne K, Petrausch U, Wolleb S, Rivalland G, Klingbiel D, Kao S, Schmid S, Nowak A, Gautschi O, Bartnick T, Hughes B, Bouchaab H, Rothschild S, Pavlakis N, John T. Brief Report: Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma. J Thorac Oncol 2018
Type
Journal Paper/Review (English)
Journal
J Thorac Oncol 2018
Publication Date
Aug 21, 2018
Issn Electronic
1556-1380
Brief description/objective